Abstract
Preeclampsia (PE) is a protean syndrome causing a transitory kidney disease, characterised by hypertension and proteinuria, ultimately reversible after delivery. Its prevalence is variously estimated, from 3 to 5% to 10% if all the related disorders, including also pregnancy-induced hypertension (PIH) and HELLP syndrome (haemolysis, increase in liver enzyme, low platelets) are included. Both nephrologists and obstetricians are involved in the management of the disease, according to different protocols, and the clinical management, as well as the role for each specialty, differs worldwide. The increased awareness of the role of chronic kidney disease in pregnancy, complicating up to 3% of pregnancies, and the knowledge that PE is associated with an increased risk for development of CKD later in life have recently increased the interest and redesigned the role of the nephrologists in this context. However, while the heterogeneous definitions of PE, its recent reclassification, an emerging role for biochemical biomarkers, the growing body of epidemiological data and the new potential therapeutic interventions lead to counsel long-term follow-up, the lack of resources for chronic patients and the increasing costs of care limit the potential for preventive actions, and suggest tailoring specific interventional strategies. The aim of the present position statement of the Kidney and Pregnancy Study Group of the Italian Society of Nephrology is to review the literature and to try to identify theoretical and pragmatic bases for an agreed management of PE in the nephrological setting, with particular attention to the prevention of the syndrome (recurrent PE, presence of baseline CKD) and to the organization of the postpartum follow-up.
Similar content being viewed by others
References
Phipps E, Prasanna D, Brima W, Jim B (2016) Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol 11(6):1102–1113
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg P (2010) Pre-eclampsia. The Lancet 376:631–644
Umans JG (2012) Obstetric nephrology: preeclampsia–the nephrologist’s perspective. Clin J Am Soc Nephrol 7:2107–2113
Dekker GA (2014) Management of preeclampsia. Pregnancy Hypertens 4(3):246–247
Roberts JM, Mascalzoni D, Ness RB, Poston L, Global Pregnancy Collaboration (2016) Collaboration to understand complex diseases: preeclampsia and adverse pregnancy outcomes. Hypertension 67(4):681–687
Fisher SJ (2015) Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol 213(4 Suppl):115–122
Redman C (2014) Pre-eclampsia: A complex and variable disease. Pregnancy Hypertens 4(3):241–242
Redman CW, Sargent IL, Staff AC (2014) IFPA Senior Award Lecture: making sense of pre-eclampsia—two placental causes of preeclampsia?. Placenta 35:S20–25
Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM (2013) Short-term outcome of patients with preeclampsia. Vasc Health Risk Manag 9:143–148
Berks D, Steegers EA, Molas M, Visser W (2009) Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 114(6):1307–1314
Ferrazzani S, De Carolis S, Pomini F, Testa AC, Mastromarino C, Caruso A (1994) The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. Am J Obstet Gynecol 171(2):506–512
http://www.acog.org. Accessed 28 Dec 2015
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ (2016) Pre-eclampsia. The Lancet 387:999–1011
Redman C (2014) The six stages of pre-eclampsia. Pregnancy Hypertens 4(3):246
Henry CS, Biedermann SA, Campbell MF, Guntupalli JS (2004) Spectrum of hypertensive emergencies in pregnancy. Crit Care Clin 20(4):697–712 ix
Remuzzi G, Ruggenenti P (1991) Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years? Am J Kidney Dis 18(3):285–305
Leeman L, Fontaine P (2008) Hypertensive disorders of pregnancy. Am Fam Physician 78(1):93–100
Myatt L, Roberts JM (2015) Preeclampsia: Syndrome or Disease? Curr Hypertens Rep 17(11):83
Williams D, Davison J (2008) Chronic kidney disease in pregnancy. BMJ 336(7637):211–215
Masuyama H, Nobumoto E, Okimoto N, Inoue S, Segawa T, Hiramatsu Y (2012) Superimposed preeclampsia in women with chronic kidney disease. Gynecol Obstet Invest 74(4):274–281
Piccoli GB, Fassio F, Attini R, Parisi S, Biolcati M, Ferraresi M et al (2012) Pregnancy in CKD: whom should we follow and why? Nephrol Dial Transplant 27(Suppl 3):iii111–i8
Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D’Amico F, Consiglio V, Bontempo S, Todros T (2010) Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 5:844–855
van der Graaf AM, Toering TJ, Faas MM, Lely AT (2012) From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system? Nephrol Dial Transplant 27(Suppl 3):iii51–i7
von Dadelszen P, Magee LA, Roberts JM (2003) Subclassification of preeclampsia. Hypertens Pregnancy 22:143–148
Lisonkova S, Joseph KS (2013) Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 209(6):544.e1-544.e12
Ciantar E, Walker JJ (2011) Pre-eclampsia, severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelets syndrome: what is new? Womens Health (Lond Engl) 7(5):555–569
Arulkumaran N, Lightstone L (2013) Severe pre-eclampsia and hypertensive crises. Best Pract Res Clin Obstet Gynaecol 27(6):877–884
Ness RB, Roberts JM (1996) Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications. Am J Obstet Gynecol 175:1365–1370
Brosens I (1964) A study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynaecol Br Commonw 71:222–230
Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683
Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y (2010) Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG 117:314–320
Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 32:189–201
Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200–1204
Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1–7
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642–649
Gilbert JS, Babcock SA, Granger JP (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50:1142–1147
Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R, McKenzie P, Kirwan P, Hennessy A (2007) Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 71:977–984
Roberts JM, Hubel CA (2009) The two stage model of preeclampsia: Variations on the theme. Placenta 30(Suppl A):S32–S37
Sircar M, Thadhani R, Karumanchi SA (2015) Pathogenesis of preeclampsia. Curr Opin Nephrol Hypertens 24(2):131–138
Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N et al (2015) Risk of Adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26(8):2011–2022
Grcevska L, Polenaković M (1992) Focal glomerular sclerosis (FGS)-like lesions are not rare in preeclampsia. Clin Nephrol 38(4):233–234
Nochy D, Hinglais N, Jacquot C, Gaudry C, Remy P, Bariety J (1986) De novo focal glomerular sclerosis in preeclampsia. Clin Nephrol 25(3):116–121
Shiiki H, Dohi K, Hanatani M et al (1990) Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome. Am J Nephrol 10(3):205–212
Kincaid-Smith P (1991) The renal lesion of preeclampsia revisited. Am J Kidney Dis 17(2):144–148
Piccoli GB, Daidola G, Attini R, et ql (2013) Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. BJOG 120(4):412–427
Rolfo A, Attini R, Tavassoli E et al (2015) Is it possible to differentiate chronic kidney disease and preeclampsia by means of new and old biomarkers? a prospective study. Dis Markers 2015:127083
Rolfo A, Attini R, Nuzzo AM et al (2013) Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int 83(1):177–181
Piccoli GB, Gaglioti P, Attini R et al (2013) Pre-eclampsia or chronic kidney disease? The flow hypothesis. Nephrol Dial Transplant 28(5):1199–1206
Piccoli GB, Cabiddu G, Attini R et al (2015) Pregnancy in chronic kidney disease: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol 29(5):625–642
Nevis IF, Reitsma A, Dominic A et al (2011) Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 6(11):2587–2598
Piccoli GB, Conijn A, Attini R et al (2011) Pregnancy in chronic kidney disease: need for a common language. J Nephrol 24(3):282–299
Costa RA, Hoshida MS, Alves EA, Zugaib M, Francisco RP (2016) Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers. Hypertens Pregnancy 35(2):139–149
Cabiddu G, Castellino S, Gernone G, et ql (2016) A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol 29(3):277–303
Zeisler H, Llurba E, Chantraine F et al (2016) Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 374(1):13–22
Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H (2014) Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth 14:324
Park HJ, Kim SH, Jung YW et al (2014) Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. BMC Pregnancy Childbirth 14:35
Forest JC, Thériault S, Massé J, Bujold E, Giguère Y (2014) Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women. Clin Chem Lab Med 52(8):1169–1178
Doherty A, Carvalho JC, Drewlo S, El-Khuffash A, Downey K, Dodds M, Kingdom J (2014) Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1/PlGF ratio before the onset of early severe preeclampsia. J Obstet Gynaecol Can 36(8):692–700
Redman CW, Staff AC (2015) Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol 213(4 Suppl):S9.e1–S9.11
Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC (2011) Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66(4):225–239
Mooney SS, Lee RM, Tong S, Brownfoot FC (2016) Expectant management of severe preterm preeclampsia: a comparison of maternal and fetal indications for delivery. J Matern Fetal Neonatal Med 3:1–6
McKinney D, Boyd H, Langager A, Oswald M, Pfister A, Warshak CR (2016) The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia. Am J Obstet Gynecol 214(3):395.e1-7
Bond DM, Gordon A, Hyett J, de Vries B, Carberry AE, Morris J (2015) Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes. Cochrane Database Syst Rev 11:CD009433
Costa ML (2015) Preeclampsia: reflections on how to counsel about preventing recurrence. J Obstet Gynaecol Can 37(10):887–893
Barton JR, Sibai BM (2008) Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112(2 Pt 1):359–372
van Oostwaard MF, Langenveld J, Schuit E et al (2015) Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am J Obstet Gynecol 212(5):624. (Erratum in: Am J Obstet Gynecol 2015; 213(3):400)
Palatnik A, Grobman WA, Miller ES (2016) Is a history of preeclampsia associated with an increased risk of a small for gestational age infant in a future pregnancy? Am J Obstet Gynecol 215(3):355.e1-6
Wise J (2016) Cardiac abnormalities may help identify women at risk of recurrent pre-eclampsia. BMJ 352:i1089. doi:10.1136/bmj.i1089
Valensise H, Lo Presti D, Gagliardi G et al (2016) Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia. Hypertension 67(4):748–753
van Kuijk SM, Delahaije DH, Dirksen CD et al (2016) For the precare Study Group. Multicenter impact analysis of a model for predicting recurrent early-onset preeclampsia: a before-after study. Hypertens Pregnancy 35(1):42–54
Stekkinger E, Scholten RR, Heidema WM, Spaanderman ME (2015) Recurrent pre-eclampsia in women with metabolic syndrome and low plasma volume: a retrospective cohort study. BJOG 122(13):1773–1780
Spradley FT, Palei AC, Granger JP (2015) Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol 309(11):R1326–R1343. 
Williams PJ, Pipkin FB (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25(4):405–417
Skomsvoll JF, Baste V, Irgens LM, Østensen M (2002) The recurrence risk of adverse outcome in the second pregnancy in women with rheumatic disease. Obstet Gynecol 100(6):1196–1202
Skjaerven R, Wilcox AJ, Lie RT (2002) The interval between pregnancies and the risk of preeclampsia. N Engl J Med 346(1):33–38
Tandberg A, Klungsoyr K, Romundstad LB, Skjærven R (2015) Pre-eclampsia and assisted reproductive technologies: consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG 122(7):915–922
England L1, Zhang J (2007) Smoking and risk of preeclampsia: a systematic review. Front Biosci 12:2471–2483
Luque-Fernandez MA, Zoega H, Valdimarsdottir U, Williams MA (2016) Deconstructing the smoking-preeclampsia paradox through a counterfactual framework. Eur J Epidemiol 31(6):613–623
Cheung KL, Lafayette RA (2013) Renal physiology of pregnancy. Adv Chronic Kidney Dis 20(3):209–214
Odutayo A, Hladunewich M (2012) Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol 7(12):2073–2080
Smyth A, Radovic M, Garovic VD (2013) Women, kidney disease, and pregnancy. Adv Chronic Kidney Dis 20(5):402–410
Dean SV, Lassi ZS, Imam AM, Bhutta ZA (2014) Preconception care: nutritional risks and interventions. Reprod Health (London) 11(Suppl 3):S3
Wilson RD; Genetics Committee (2015) Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can 37(6):534–552
Wei SQ (2014) Vitamin D and pregnancy outcomes. Curr Opin Obstet Gynecol 26(6):438–447
Harvey NC, Holroyd C, Ntani G et al (2014) Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess 18(45):1–190
Agrawal S, Fledderjohann J, Vellakkal S, Stuckler D (2015) Adequately diversified dietary intake and iron and folic acid supplementation during pregnancy is associated with reduced occurrence of symptoms suggestive of pre-eclampsia or eclampsia in Indian women. PLoS One 10(3):e0119120
Basu A, Yu JY, Jenkins AJ et al (2015) Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutr Res 35(5):421–430
Kim J, Kim YJ, Lee R, Moon JH, Jo I (2012) Serum levels of zinc, calcium, and iron are associated with the risk of preeclampsia in pregnant women. Nutr Res 32(10):764–769
Villa PM, Kajantie E, Räikkönen K et al PREDO Study group (2013) Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 120(1):64–74
LeFevre ML, US Preventive Services Task Force (2014) Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 161(11):819–826
Werner EF, Hauspurg AK, Rouse DJ (2015) A Cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol 126(6):1242–1250
Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD (2015) Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk aspirin study. J Perinatol 35(5):328–331
Vikse BE, Irgens LM, Bostad L, Iversen BM (2006) Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 17(3):837–845
Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359(8):800–809
McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ (2010) Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 55(6):1026–1039
Sandvik MK, Hallan S, Svarstad E, Vikse BE (2013) Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol 8(7):1126–1134
Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E (2015) Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 101(6):442–446
Lewandowski AJ, Leeson P (2014) Preeclampsia, prematurity and cardiovascular health in adult life. Early Hum Dev 90(11):725–729
Charlton F, Tooher J, Rye KA, Hennessy A (2014) Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ 23(3):203–212
Pauli JM, Repke JT (2015) Preeclampsia: Short-term and Long-term Implications. Obstet Gynecol Clin North Am 42(2):299–313
Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V (2014) Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 63(18):1815–1822
Scantlebury DC, Hayes SN (2014) How does preeclampsia predispose to future cardiovascular disease? Curr Hypertens Rep 16(9):472
Piccoli GB, Cabiddu G, Attini R et al (2016) Hypertension in CKD pregnancy: a question of cause and effect (cause or Effect? this is the question). Curr Hypertens Rep 18(5):35
Wu CS, Nohr EA, Bech BH, Vestergaard M, Catov JM, Olsen J (2009) Health of children born to mothers who had preeclampsia: a population-based cohort study. Am J Obstet Gynecol 201(3):269.e1-269.e10
Geelhoed JJ, Fraser A, Tilling K et al (2010) Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation 122(12):1192–1199
Staley JR, Bradley J, Silverwood RJ et al (2015) Associations of blood pressure in pregnancy with offspring blood pressure trajectories during childhood and adolescence: findings from a prospective study. J Am Heart Assoc 4(5):pii:e001422. doi:10.1161/JAHA.114.001422
Fraser A, Nelson SM, Macdonald-Wallis C, Sattar N, Lawlor DA (2013) Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension 62(3):614–620
Sutherland M, Ryan D, Black MJ, Kent AL (2014) Long-term renal consequences of preterm birth. Clin Perinatol 41(3):561–573
Bartnik P, Kosinska-Kaczynska K, Kacperczyk J et al (2016) Twin chorionicity and the risk of hypertensive disorders: gestational hypertension and pre-eclampsia. Twin Res Hum Genet 10:1–6
Bdolah Y, Lam C, Rajakumar A et al (2008) Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 198(4):428.e1-6
Fox NS, Roman AS, Saltzman DH, Hourizadeh T, Hastings J, Rebarber A (2014) Risk factors for preeclampsia in twin pregnancies. Am J Perinatol 31(2):163–166
Mastrobattista JM, Skupski DW, Monga M, Blanco JD, August P (1997) The rate of severe preeclampsia is increased in triplet as compared to twin gestations. Am J Perinatol 14(5):263–265
Skrablin S, Kuvacić I, Pavicić D, Kalafatić D, Goluza T (2000) Maternal neonatal outcome in quadruplet and quintuplet versus triplet gestations. Eur J Obstet Gynecol Reprod Biol 88(2):147–152
Piccoli GB, Arduino S, Attini R et al (2013) Multiple pregnancies in CKD patients: an explosive mix. Clin J Am Soc Nephrol 8(1):41–50
Licciardi F (2016) Toward a better understanding of the oocyte donation/pre-eclampsia connection. Fertil Steril 106(2):267
Blázquez A, García D, Rodríguez A, Vassena R, Figueras F, Vernaeve V (2016) Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis. J Assist Reprod Genet 33(7):855–863
Masoudian P, Nasr A, de Nanassy J, Fung-Kee-Fung K, Bainbridge SA, El Demellawy D (2016) Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol 214(3):328–339
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Conflicts of interest
The authors declare they have no conflict of interest.
Additional information
This article is part of the topical collection on Obstetric Nephrology.
Rights and permissions
About this article
Cite this article
Piccoli, G.B., Cabiddu, G., Castellino, S. et al. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J Nephrol 30, 307–317 (2017). https://doi.org/10.1007/s40620-017-0390-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-017-0390-1